Mayo Clinic has a robust research program focused on clinical, translational, and basic sciences research related to endometriosis. They have developed a two-marker methylated DNA assay capable of detecting endometrial cancer with high sensitivity and specificity.

MD Anderson is recognized for its research in cancer genetics, particularly in endometrial carcinoma. They have identified significant genetic mutations that contribute to the understanding of endometrial cancer.

Duke University is known for its contributions to gynecologic oncology research, particularly through its lead study authors who are actively involved in clinical trials and studies.

TCGA has conducted extensive genomic analyses of endometrial carcinomas, providing valuable insights into the genetic landscape of these cancers.

The National Cancer Institute plays a pivotal role in cancer research and has spearheaded collaborative efforts to advance the understanding of endometrial cancer.